Livostin Neusspray 10 spr
Livostin Neusspray 10 spr
Livostin Neusspray 10 spr
Livostin Neusspray 10 spr

Livostin Neusspray 10 spr

MCNEIL COMM
0251272
€12.44
Tax included
Indications:

 

Livostin Neusspray 10 spr

.

Indications:

Livostin-nasal spray is indicated for a rapid and sustained relief of symptoms of allergic rhinitis (both seasonal and perennial form) .

Composition:


levocabastine. hydrochlorid. 0.5 mg (R 50 547) - Benzalkon. chlorid. 50% ige asc. 0.294 mg - Propylen. glycol. - Polysorbate. 80 - Natr. monohydrogenophosph. - Natr. dihydrogenophosph. - Dinatr. Edet. - Hypromellose. - Aqua q.s. ad 1 ml.
Livostin nasal spray is a micro-suspension with a pH 6 to 8.

Posology and method of use:


Children from 3 to 12 years.

1 spray Livostin-nasal spray per nostril, 2 times a day.
Adults.

Livostin-nasal spray 2 sprays per nostril, 2 times a day.
If serious symptoms to 3 to 4 times a day are given the necessary spray. Since Livostin-nasal spray is a suspension, the bottle must be shaken before each use. We will advise patients to use the spray before the passage of the nose during the purification and sprays to breathe through the nose.

This is a drug, not prolonged use without medical advice, keep away from children, read the leaflet carefully. Ask your doctor or pharmacist. In case of side effects, contact your doctor.

Contraindications:


for a
Hypersensitivity of the ingredients.
Since levocabastine in a significantly renally eliminated, would allow patients with pronounced chronic renal failure using the spray-Livostin avoid.

Special precautions:


Infectious rhinitis is not an indication for Livostin.

Pregnancy and lactation:


Pregnancy.

Reproductive studies in rodents, which systemically to 1,250 times the maximum clinical dose of 0.016 mg / kg / day was administered levocabastine showed no detrimental effect on fertility. These extremely high doses caused no fetal abnormalities.
At present no data on the intake of levocabastine during pregnancy. It is recommended to use Livostin-spray only when the expected benefits outweigh the potential risk to the fetus.
Lactation.

Based on the provisions of the levocabastineconcentraties saliva and breast milk was calculated that the amount of levocabastine daily by the child included does not exceed 3.5 micrograms after nasal treatment of the mother. Livostin spray-can therefore be used by nursing mothers.

Undesirable effects:


Occasionally, a mild and transient local irritation reported immediately after the use of spray-Livostin. Allergic reactions were reported rarely.

driving and using machines:


Compared with placebo, caused Livostin nasal spray in general no clinically relevant sedation or disruption of psychomotor function. Therefore, in the use of spray-Livostin not expect interference with the driving or using machinery. If drowsiness occurs, it is advisable to be careful.

Overdose:


There are no known cases of toxic side effects following topical overdose. In an accidental oral ingestion of the contents of the bottle is not ruled out any sedation. In that case, the patient may be advised to drink much, so the renal excretion of levocabastine accelerated.

Interactions:


any local interactions with other nasal preparations are not sufficiently studied, except with oxymetazoline with no negative interaction was found. There was no established systemic interaction with other drugs. The effects of alcohol or diazepam are not potentiated by the use of Livostin-nasal spray in normal doses.

 

Delivery form
Spray
Type of product
Medicine
Brands
Johnson & Johnson
No reviews

16 other products in the same category:

Product added to wishlist
Product added to compare.

We use cookies to provide you with the best possible service. By visiting our website you agree to the placing of cookies.